When we hear sounds, specialized cells in the cochlear nucleus are the first to process that information, enabling our brains to understand speech, enjoy music and recognize various noises. For ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
Cochlear™ is proud to announce FDA approval for the Cochlear Nucleus® Hybrid Implant System. The system is a groundbreaking advancement that will change the way hearing loss is treated in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback